Sunmark Nite Time
Loading...Sunmark Nite Time Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Limitation of Use
When prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy
due to menopause, topical vaginal products should be considered.
History
There is currently no drug history available for this drug.
Other Information
Cenestin (synthetic conjugated estrogens, A) tablets contain a blend of nine (9) synthetic estrogenic substances. The estrogenic substances are sodium estrone sulfate, sodium equilin sulfate, sodium 17α-dihydroequilin sulfate, sodium 17α-estradiol sulfate, sodium 17β-dihydroequilin sulfate, sodium 17α-dihydroequilenin sulfate, sodium 17β-dihydroequilenin sulfate, sodium equilenin sulfate and sodium 17β-estradiol sulfate.
The structural formulae for these estrogens are:
Sodium Estrone Sulfate
Sodium Equilin Sulfate
Sodium 17α-Dihydroequilin Sulfate
Sodium 17α-Estradiol Sulfate
Sodium 17β-Dihydroequilin Sulfate
Sodium 17α-Dihydroequilenin Sulfate
Sodium 17β-Dihydroequilenin Sulfate
Sodium Equilenin Sulfate
Sodium 17β-Estradiol Sulfate
Tablets for oral administration, are available in 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg strengths of synthetic conjugated estrogens, A. Tablets also contain the following inactive ingredients: ethylcellulose, hypromellose, lactose monohydrate, magnesium stearate, polyethylene glycol, polysorbate 80 (except 0.45 mg tablets ), pregelatinized starch, titanium dioxide, and triethyl citrate.
-
- •
- 0.3 mg tablets also contain FD&C Blue No. 2 aluminum lake and D&C Yellow No. 10 aluminum lake.
- •
- 0.45 mg tablets also contain FD&C Yellow No. 6/Sunset Yellow FCF lake.
- •
- 0.625 mg tablets also contain FD&C Red No. 40 aluminum lake.
- •
- 0.9 mg tablets do not contain additional color additives.
- •
- 1.25 mg tablets also contain FD&C Blue No. 2 aluminum lake.
Sources
Sunmark Nite Time Manufacturers
-
Mckesson
![Sunmark Nite Time (Acetaminophen, Dextromethorphan Hbr, Doxylamine Succinate) Liquid [Mckesson]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Sunmark Nite Time | Teva Women's Health, Inc.
Generally, when estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be considered to reduce the risk of endometrial cancer.
A woman without a uterus does not need progestin. In some cases, however, hysterectomized women with a history of endometriosis may need a progestin [see Warnings and Precautions (5.2, 5.14)].
Use of estrogen-alone, or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Postmenopausal women should be reevaluated periodically as clinically appropriate to determine if treatment is still necessary.
2.1 Treatment of Moderate to Severe Vasomotor Symptoms due to MenopauseCenestin therapy consists of a single tablet taken orally once daily.
• Cenestin 0.45 mg • Cenestin 0.625 mg • Cenestin 0.9 mg • Cenestin 1.25 mgPatients should be started at Cenestin 0.45 mg daily. Subsequent dosage adjustment may be made based upon the individual patient response. This dose should be periodically reassessed by the healthcare provider. The lowest effective dose of Cenestin for the treatment of moderate to severe vasomotor symptoms has not been determined.
2.2 Treatment of Moderate to Severe Symptoms of Vulvar and Vaginal Atrophy due to MenopauseCenestin therapy consists of a single tablet taken orally once daily.
• Cenestin 0.3 mgWhen prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered.
-
Mckesson
Sunmark Nite Time | Cardinal Health
• take only as directed – see Overdose warning • use dose cup • do not exceed 4 doses per 24 hrsadults & children 12 yrs & over
30 mL (2 TBSP) every 6 hrs
children 4 to under 12 yrs
ask a doctor
children under 4 yrs
do not use
![Sunmark Nite Time (Acetaminophen, Dextromethorphan Hbr, Doxylamine Succinate) Liquid [Mckesson]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=baa874d8-3c1d-4b3d-b415-0264834a4aad&name=e5595a8c-00c1-4dfc-bfc3-a79d6273b67a-01.jpg)
Login To Your Free Account